Javier B. Szwarcberg - 30 Jun 2026 Form 4 Insider Report for SPRUCE BIOSCIENCES, INC. (SPRB)

Reporting relationship: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: SPRB
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jul 2026, 16:15:05 UTC
Prior SEC filing: 05 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Samir Gharib, Attorney-in-Fact

Key filing fact

Javier B. Szwarcberg filed Form 4 for SPRUCE BIOSCIENCES, INC. (SPRB) on 09 Jul 2026.

Key facts

This page summarizes Javier B. Szwarcberg's Form 4 filing for SPRUCE BIOSCIENCES, INC. (SPRB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 09 Jul 2026, 16:15.

Change

Previous filing in this sequence was filed on 05 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001903669 Primary reporting owner

Szwarcberg Javier B.

Relationship: CHIEF EXECUTIVE OFFICER, Director
Address: C/O SPRUCE BIOSCIENCES, INC., 611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO
Signature: /s/ Samir Gharib, Attorney-in-Fact
Signature date: 09 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SPRB transaction

Common Stock

Award

Transaction value
Shares: +266
Change %: +1.4%
Price: $4.53^*
Shares after: 19,270
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).